Migraine visual aura is a temporary neurological disturbance that produces vivid visual symptoms, typically shimmering zigzag lines, spreading blind spots, or flashing lights, in the minutes before or during a migraine headache. It affects roughly a quarter to a third of people who have migraine, and the visual show usually lasts between five and sixty minutes. What makes it remarkable is not just the experience itself but the underlying brain event driving it: a slow wave of electrical and chemical disruption rolling across the visual cortex like a ripple across water.
What Visual Aura Actually Looks Like
The classic migraine aura starts as a small flickering spot near the center of your vision. Over the next twenty to thirty minutes, it expands outward into a crescent or horseshoe shape, often described as a “fortification spectrum” because the zigzag pattern resembles the walls of a medieval fortress viewed from above. The leading edge of this crescent tends to shimmer or scintillate with bright, jagged lines, while the area it leaves behind may go temporarily dark or blurry, creating a scotoma, or blind spot. The whole thing drifts slowly across your visual field, usually affecting the same side in both eyes, and then fades.
Not everyone gets the textbook zigzag pattern, though. Some people see sparkles, colored dots, heat-wave distortions, or simple flashes. Others experience their aura as a gradually expanding patch of blurriness or a shimmering “halo” effect. The visual disturbance almost always moves and changes shape over time, which turns out to be one of the most important clues to what is happening in the brain.
The Brain Event Behind the Visuals
The leading explanation for migraine aura is a phenomenon called cortical spreading depression, or CSD. This is a wave of intense nerve cell excitation followed almost immediately by a prolonged period of electrical silence, sweeping slowly across the surface of the brain. The wave travels at roughly two to five millimeters per minute and is accompanied by massive shifts in the concentrations of ions like potassium and calcium, along with a surge in the excitatory brain chemical glutamate.
A landmark functional MRI study directly observed this process in people experiencing visual aura. The researchers tracked blood-flow changes across the visual cortex in real time and found a signal that progressed slowly, at about 3.5 millimeters per minute, matching the movement of the visual disturbance the subjects reported. The expanding wave of activity followed the brain’s visual map precisely: as it rolled through regions that process the center of vision, the aura appeared centrally; as it reached areas handling peripheral vision, the percept expanded outward. The initial blood-flow increase was followed by a decrease, consistent with the excitation-then-suppression pattern of CSD.
This finding was significant because CSD had been observed in animal brains since the 1940s but proving it happened in living human brains during a migraine aura required catching someone mid-aura inside a scanner. The MRI data matched at least eight predicted characteristics of CSD, providing strong evidence that this slow electrical wave is what generates the aura experience.
Why the Aura Precedes the Headache
One of the most common questions people have is why the visual disturbance tends to arrive before the pain. The CSD wave does not stay contained in the visual cortex. As it propagates, it triggers inflammatory signals and activates pain-sensitive nerve fibers in the meninges, the membranes surrounding the brain. This inflammatory cascade takes time to build, which is why the headache often starts as the aura is fading or shortly after it ends. In some people, though, the headache begins during the aura, and in others the aura occurs with no headache at all. The relationship between the wave and the pain is not perfectly synchronized, which is part of why aura-only episodes exist.
Beyond Zigzag Lines
Visual aura gets most of the attention because the visual cortex sits at the back of the brain, where CSD often originates. But the wave can spread into adjacent brain regions, producing symptoms that go well beyond vision. Some people experience tingling or numbness that creeps up one hand and arm, or temporary difficulty finding words and speaking. These are sensory and language auras, and they follow the same slow-march pattern because the CSD wave is rolling through the corresponding areas of cortex.
Even within the visual domain, the range of possible experiences is wider than many people realize. A study of migraine patients found that a substantial proportion reported disturbances in color perception, face recognition, and spatial awareness during attacks, suggesting the wave can disrupt higher-order visual processing, not just the basic perception of light and edges.
Perhaps the most striking variant is Alice in Wonderland syndrome, a set of perceptual distortions where objects or body parts appear to change size, shrink, grow, or warp. In a study of over 800 migraine patients, about one in six reported experiencing these symptoms at some point in their lives. The most common distortion was perceiving objects as abnormally small or far away. People with aura were more likely to report these experiences than those without aura, and the episodes lasted on average around half an hour.
Genetics and Who Gets Aura
Migraine with aura and migraine without aura appear to have partially distinct genetic underpinnings. A large genome-wide study combining data from six European populations identified four new genetic variants specifically associated with migraine with aura, in genes including PRRT2, PALMD, ABO, and LRRK2. Separately, thirteen variants were linked specifically to migraine without aura. This genetic separation helps explain why some families seem to pass down the aura trait while others pass down migraine without it.
The clearest genetic link to aura comes from familial hemiplegic migraine, a rare inherited form where attacks include temporary paralysis on one side of the body along with typical aura symptoms. Researchers identified the first causative mutations in a calcium channel gene in the mid-1990s, and follow-up work showed that these mutations alter how the channel opens and closes, essentially making neurons more prone to the kind of runaway excitation that triggers CSD. Familial hemiplegic migraine is extreme and uncommon, but studying it has been invaluable for understanding the broader biology of aura. The calcium channel mutations create a lower threshold for the spreading wave, and common migraine with aura likely involves subtler versions of the same basic vulnerability: a cortex that is a bit too excitable, a bit too ready to tip into a CSD event.
The Patent Foramen Ovale Connection
One of the more surprising findings in aura research involves a small hole in the heart called a patent foramen ovale, or PFO. Everyone has this opening before birth, and it usually closes shortly after. In roughly a quarter of the general population, though, it never fully seals. Studies have found that PFOs are far more common in people who have migraine with aura than in the general population or in migraine patients without aura. One study reported that about 47% of migraine-with-aura patients had a PFO, compared with 17% of controls, and that having a moderate-to-large shunt increased the odds of migraine with aura nearly eightfold.
The incidence range across studies is wide. One review found PFO rates of 46% to 88% in migraine-with-aura patients, compared with 16% to 35% in migraine patients without aura.
Why would a heart defect be linked to a brain phenomenon? The leading theory is that a PFO allows tiny blood clots or chemical signals that would normally be filtered out by the lungs to pass directly into the arterial circulation and reach the brain, where they could trigger CSD. Experimental work supports this idea: mild, transient blood-flow disruptions have been shown to provoke CSD in animal models. Some case series have found that surgically closing the PFO reduced or eliminated aura symptoms in a majority of patients, with one study reporting resolution of aura in roughly 52% to 80% of patients across different groups at twelve months.
This does not mean everyone with aura should rush to get their heart checked. PFO closure for migraine is not an established standard of care, and randomized controlled trials have produced mixed results on whether closing the hole reliably prevents migraine attacks. The association is real and biologically interesting, but translating it into a treatment has proven difficult.
Visual Cortex Sensitivity and Triggers
People who get migraine with aura tend to have visual cortexes that respond differently to stimulation even between attacks. Research on flicker sensitivity found that people with migraine were more sensitive to flickering light than those without, aborting a visual stimulus at a lower level of contrast. The study also found that visual discomfort scores were strongly correlated with how many years a person had been living with migraine, suggesting that the brain’s sensitivity may increase over time.
This heightened excitability helps explain common aura triggers. Bright or flickering lights, strong visual patterns, glare, and even transitions from dark to bright environments can nudge an already-excitable visual cortex closer to the threshold for CSD. Stress, sleep disruption, and hormonal fluctuations are also well-known triggers, though these likely act through broader brain chemistry changes rather than directly poking the visual cortex.
Visual Snow Syndrome Is Not Aura
A condition that gets confused with migraine aura is visual snow syndrome, where people see a constant field of tiny flickering dots across their entire vision, like static on an old television set. Because many visual snow patients also have migraine, and because the symptoms are visual, the two often get lumped together. They should not be.
Visual snow is persistent. It does not come in episodes, does not build over minutes and resolve, and does not follow the migraine cycle. A large study characterizing 78 confirmed visual snow patients found that one-quarter had experienced the static for as long as they could remember, while others developed it around age 21 on average. For many, the symptoms either stayed constant or gradually worsened over time. Migraine was a common comorbidity, present in about 59% of cases, but standard migraine treatments were often unhelpful for the visual snow itself.
Brain imaging studies have reinforced the distinction. People with visual snow show abnormalities in brain networks involved in attention and sensory filtering that are different from the patterns seen in migraine with aura. One study found that visual snow patients had reduced connectivity in glutamate-related networks in the anterior cingulate cortex compared to both healthy controls and migraine patients, while migraine-with-aura patients showed their own distinct pattern of serotonin-network changes. The two conditions can coexist and may share some underlying neurobiology, but their core mechanisms appear to be separate.
The practical implication is important: if you have constant visual static and have been told it is “just your migraines,” it may be worth raising visual snow syndrome with your neurologist. The treatments differ, and a correct diagnosis matters for management.
Stroke Risk and Migraine with Aura
Migraine with aura carries a modestly elevated risk of ischemic stroke compared with migraine without aura or no migraine at all. The association has been documented across multiple large studies and is one of the reasons doctors pay attention to whether someone’s migraine includes aura. The absolute risk remains small for most people, but it becomes more relevant when other risk factors are present, particularly smoking and the use of estrogen-containing oral contraceptives. Many prescribing guidelines recommend against combined hormonal birth control for women who have migraine with aura, specifically because of this compounding stroke risk.
The biological explanation ties back to CSD. The spreading wave causes temporary blood-flow changes in the brain, and in the presence of vascular risk factors like those produced by smoking or estrogen exposure, these transient disruptions may occasionally tip into lasting damage. PFO, with its potential to allow microemboli through to the brain, may add yet another layer of vulnerability in some patients.
Treating the Aura Itself
Most migraine treatments focus on the headache, but for people whose aura is frequent, prolonged, or genuinely disruptive to daily life, targeting the aura specifically becomes a priority. The two approaches with the most evidence are a medication called lamotrigine and a device-based therapy called single-pulse transcranial magnetic stimulation.
Lamotrigine is an anti-seizure drug that stabilizes nerve cell membranes and reduces the release of glutamate, the same excitatory chemical that surges during CSD. In an open study of 44 patients with particularly troublesome aura, 68% responded to lamotrigine, with monthly aura frequency dropping from an average of 4.2 episodes to 0.7. Among responders, 70% had an excellent response, defined as more than 75% reduction in aura episodes. When the drug was stopped, auras returned within two months in most cases and ceased again when it was restarted. A larger retrospective study found similar results, with an 85% response rate and a roughly 80% reduction in monthly aura days. Retrospective comparisons have suggested that lamotrigine may be somewhat better than topiramate specifically at reducing aura frequency and duration, though both drugs help with the overall headache burden.
Single-pulse transcranial magnetic stimulation, or sTMS, is a non-drug approach. A handheld device delivers a brief magnetic pulse to the back of the head during an aura, with the goal of disrupting the CSD wave before it fully propagates. A randomized, sham-controlled trial found that 39% of patients treated with real sTMS during an aura were pain-free at two hours, compared with 22% of those who received a sham pulse, and the benefit held at 24 and 48 hours post-treatment.
An interesting wrinkle has emerged with the newer anti-CGRP medications, which are the most significant recent advance in migraine prevention overall. An observational study found that while these drugs effectively reduced headache intensity and duration, they did not appear to reduce the frequency of aura episodes themselves. Some patients even reported experiencing aura attacks without any subsequent headache during treatment, as though the drug blocked the pain cascade but left the cortical wave untouched. This makes biological sense: CGRP acts mainly on the pain-signaling side of the migraine process, downstream of the aura-generating CSD event.
Children and Aura
About one-third of children and adolescents with migraine experience aura, a proportion similar to adults. But pediatric aura can look different enough to cause diagnostic confusion. Children are less articulate about visual disturbances, and their auras tend to be shorter and sometimes harder to separate from the headache itself. Alice in Wonderland syndrome is particularly associated with younger patients. In the large study of over 800 migraine patients, more than half of those who reported Alice in Wonderland experiences said their first episode occurred at age 18 or younger.
For parents, the key thing to know is that childhood aura is not dangerous in itself, though it can be frightening for a child who does not understand what is happening. A calm explanation that the visual disturbance will pass in a few minutes is often more helpful than anything else in the moment.
Aura in Art and History
The visual patterns produced by migraine aura have left traces throughout art history. The most famous case is Hildegard von Bingen, a twelfth-century German nun, mystic, composer, and medical writer whose elaborate illustrations of divine visions bear a striking resemblance to the visual phenomena of migraine aura: radiating fortification patterns, scintillating edges, and central areas of darkness or brilliance. The neurologist Oliver Sacks argued that many of Hildegard’s visions were likely migraine auras interpreted through a religious framework, a reading that has gained wide acceptance among neurologists if not among all historians.
Whether or not every historical “vision” was a migraine, the connection is a useful reminder that aura is not a modern invention. People have been experiencing these brain events for as long as there have been human brains, and interpreting them through whatever cultural lens was available. Today’s lens happens to be cortical spreading depression and functional MRI. Hildegard’s was theology. The underlying neurology was the same.